|
 |
| |
| Licensing & Royalties >> Licensing Opportunities >> Technology Abstracts |
|
| |
Gene Based Therapies
- Therapeutics:
| Date | Ref. No. | Patent No. | Title | | 10/28/2009 | E-296-2009/0 | | Novel Inhibitors of Interleukin-6 for Kaposi Sarcoma Therapy | | 9/3/2009 | E-169-2004/0
E-281-2005/0
E-318-2000/0 | | Rapid Diagnostic Applications of Phage | | 8/5/2009 | E-184-2001/1 | 7,271,150 | Modified Growth Hormone | | 7/2/2009 | E-196-2004/0 | | Bone Morphogenetic Variants, Compositions and Methods of Treatment | | 7/2/2009 | E-127-1995/0
E-127-1995/1
E-127-1995/2
E-138-1994/0
E-196-2004/0 | 6,884,871
6,924,367
7,049,291
7,148,036
7,220,558
7,563,596 | Novel Osteobiologic Proteins for Treatment of Osteoporosis, Rheumatoid and Neurologic Diseases | | 5/28/2009 | E-043-2009/0 | | T Cells Attacking Cancer: T Cell Receptors that Recognize the Tyrosinase Tumor Antigen | | 5/5/2009 | E-092-2008/0 | | Novel Oligonucleotides for Treatment of Human Cancer | | 5/4/2009 | E-223-2003/1 | | Improved Expression Vectors for Mammalian Use | | 1/9/2009 | E-278-2007/0 | | Attenuated Salmonella as a Delivery System for siRNA-Based Tumor Therapy | | 1/1/2009 | E-051-2008/0 | | A Novel and Efficient Technology for Targeted Delivery of siRNA | | 11/1/2008 | E-308-2001/0 | 7,419,817 | Scalable Purification of AAV2, AAV4 or AAV5 Using Ion-Exchange Chromatography | | 11/1/2008 | E-174-2008/0 | | Therapeutic Targeting of CSN5, a Negative Regulator of p53 and p27, in Human Hepatocellular Carcinoma | | 7/1/2008 | E-154-2006/0 | | Use of Human Gamma Satellite Insulator Sequences to Prevent Gene Silencing and Allow for Long Term Expression of Integrated Transgenes | | 5/1/2008 | E-096-2000/0 | 7,531,352 | The Use of an Inducible Plasmid Vector Encoding for Active TGF-beta for the Treatment of Autoimmune Diseases | | 2/1/2008 | E-069-2000/2
E-069-2000/3 | 7,196,074 | Preparation and Use of Androgenic Compounds | | 11/1/2007 | E-061-2007/0 | | Diagnostic Ovarian Cancer Biomarkers | | 8/1/2007 | E-179-2005/0 | | Isolation, Cloning and Characterization of New Adeno-Associated Virus (AAV) Serotypes | | 8/1/2007 | E-104-2006/0 | | Immunogenic Peptides and Methods of Use for Treating Prostrate and Uterine Cancers | | 8/1/2007 | E-215-2007/0 | | Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells | | 7/1/2007 | E-118-2005/0 | | A Gene Therapy to Treat Lung Cancer | | 6/1/2007 | E-042-1998/0 | 6,897,018
7,534,565 | DLC-1 Gene Deleted in Cancers | | 6/1/2007 | E-310-2001/0 | | Identification of Ovarian Cancer Tumor Markers and Therapeutic Agents | | 3/1/2007 | E-105-2003/0 | | Cloning and Characterization of an Avian Adeno-Associated Virus and Uses Thereof | | 2/1/2007 | E-231-1998/0 | 6,790,657
7,226,780 | Lentivirus Vector System | | 5/1/2006 | E-200-2005/0 | | Insect Cell Production of Recombinant Adeno-Associated Virus that Produce Cytotoxic Gene Products and Applications for Solid Tumor Therapy | | 5/1/2006 | E-090-2006/0 | | Adoptive Immunotherapy with Autologous Natural Killer Cells | | 5/1/2006 | E-176-1998/1 | | Anti-Notch-1 Monoclonal Antibodies for Inducing Cellular Differentiation and Apoptosis | | 3/1/2006 | E-045-1995/0 | 6,984,379 | Gene Therapy by Administration of Genetically Engineered CD34+ Obtained by Cord Blood | | 3/1/2006 | E-128-2005/0 | | Rapid Methods for Human Artificial Chromosome (HAC) Formation | | 1/1/2006 | E-298-2004/0 | | Transcytosis of Adeno-Associated Viruses | | 10/1/2005 | E-127-1998/0 | 6,984,517
7,479,554 | AAV5 Vector and Uses Thereof | | 6/1/2005 | E-138-2005/0 | | Infectious Particle Composition and Methods of Use Thereof | | 3/1/2005 | E-281-1999/0 | 7,087,736 | Tyrosyl-DNA Phosphodiesterases (TDP) and Related Polypeptides, Nucleic Acids, Vectors, TDP-Producing Host Cell, Antibodies and Methods of Use | | 2/1/2005 | E-204-2001/0 | 7,314,712 | Rapid, Efficient In Vivo Site-Directed Mutagenesis Using Oligonucleotides | | 11/1/2004 | E-233-2004/0
E-233-2004/1 | | Anti-HIV Peptide Secreting Bacteria: Therapeutics and Methods of Use | | 11/1/2004 | E-178-2004/0 | 7,598,071 | Infectious Clone of Human Parvovirus B19 and Methods of Use | | 9/1/2004 | E-312-2000/0 | 7,226,779 | Hybrid Adeno-Retroviral Vector for the Transformation of Cells (E-312-2000) | | 8/1/2004 | E-040-1996/0 | 6,734,014
7,378,277 | Methods and Compositions for Transforming Dendritic Cells and Activating T Cells | | 8/1/2004 | E-325-2001/1
E-325-2001/2 | 6,723,551
7,271,002 | Production of Adeno-Associated Viruses in Insect Cells | | 4/1/2004 | E-073-2004/0 | | Reduction of HIV-1 Replication by a Mutant Apolipoprotein B mRNA Editing Enzyme-Catalytic Polypeptide-like 3G (APOBEC3G) | | 4/1/2004 | E-326-2002/0
E-326-2002/2 | | Triplex Hairpin Ribozyme | | 4/1/2004 | E-258-1998/0 | 7,052,904
7,618,623 | Hybrid Adeno-Retroviral Vector for the Transformation of Cells (E-258-1998) | | 2/1/2004 | E-006-1991/1
E-139-1995/0
E-166-1995/0
E-196-1993/0 | 5,460,941
5,510,473
5,707,811
5,731,411 | Homologous DNA Recombination | | 12/1/2003 | E-191-2001/0 | | gp64 Pseudotyped Vectors and Uses Thereof | | 11/1/2003 | E-038-2003/0 | | High Efficiency Single Stranded Homologous Recombination in Host Cells Deficient for Mismatch Repair | | 11/1/2003 | E-008-2001/0 | 7,598,077 | Compositions and Methods for Enhancing Differential Gene Expression | | 10/1/2003 | E-001-2003/0
E-001-2003/1
E-019-2003/0 | | Methods and Materials for Controlling Stem Cell and Cancer Cell Proliferation and Differentiation | | 8/1/2002 | E-165-2001/0 | | Maxp1, A New Tumor Suppressor Regulated by Ras | | 5/1/2002 | E-284-2001/0 | | Specific Inhibition of Gene Expression by Small Double Stranded RNAs | | 5/1/2002 | E-206-2000/0
E-206-2000/1 | | Enhanced Distribution of Therapeutic Agents After Local Delivery | | 3/1/2002 | E-253-2000/0 | | Artificial Chromosomes That Can Shuttle Between Bacteria, Yeast, and Mammalian Cells | | 8/1/2001 | E-264-2001/0 | H2,056 | A Mouse Model of von Hippel-Lindau Disease | | 4/1/2001 | E-088-1999/0 | 6,949,624 | Cloning of the Human Nuclear Receptor Co-Repressor Gene | | 2/1/2001 | E-174-1998/0 | 6,974,698 | Methods for Delivering Biologically Active Molecules into Cells | | 12/1/2000 | E-170-2000/0 | 7,141,661 | NAG-1: A Non-Steroidal Anti-Inflammatory Drug Related Gene Which Has Anti-Tumorigenic Properties | | 11/1/2000 | E-177-2000/2 | 7,144,734 | Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins | | 7/1/2000 | E-087-2000/0 | 7,358,090 | Establishment of Cellular Manipulations Which Enhance Oligo-Mediated Gene Targeting | | 4/1/2000 | E-194-1998/0 | 6,441,156
6,979,724 | Calcium Channel Compositions and Methods of Use Thereof | | 9/1/1999 | E-059-1996/0 | 6,686,333 | Inhibition of HIV Replication Using Soluble Tat Peptide Analogs | | 7/1/1999 | E-200-1997/0 | 6,479,465 | Methods of Treating Colitis Using STAT-4 Antisense Oligonucleotide | | 6/1/1999 | E-011-1997/0 | 6,238,858 | Transgenomic Viruses | | 2/1/1999 | E-113-1995/2 | 5,942,433
6,361,968 | Extension Of A Protein-Protein Interaction Surface To Inactivate The Function Of A Cellular Protein | | 1/1/1999 | E-099-1990/0 | 5,474,935 | Adeno-Associated Virus (AAV)-Based Eucaryotic Vectors | | 12/1/1998 | E-066-1996/0 | | AAV4 Vector And Uses Thereof | | 12/1/1998 | E-128-1998/0 | | Use of Constitutive Transport Elements to Control the Host Range of Retroviral Vectors | | 8/1/1997 | E-011-1997/0 | 6,238,858 | Transgenic And Chimeric Viral Delivery Systems | | 1/1/1997 | E-093-1995/0 | 5,830,755 | T-Cell Receptors And Their Use In Therapeutic And Diagnostic Methods | | 4/1/1996 | E-169-1993/0 | 5,990,088 | Method For Treatment Of Kaposi's Sarcoma (KS) By Antisense Oligonucleotides | | 4/1/1996 | E-099-1994/0 | | Avian Based Retrovirus Vectors |
|
| Back |
|
|
|
|
|
|